<?xml version='1.0' encoding='utf-8'?>
<section xmlns="https://code.dccouncil.us/schemas/dc-library" xmlns:codified="https://code.dccouncil.us/schemas/codified" xmlns:codify="https://code.dccouncil.us/schemas/codify" xmlns:xi="http://www.w3.org/2001/XInclude" containing-doc="D.C. Code">
  <num>31-2993.02</num>
  <heading>Covered trials.</heading>
  <para>
    <num>(a)</num>
    <text>A health insurer shall not limit or deny coverage, or impose additional conditions on the payment for the coverage, of routine patient care costs of items, drugs, and services furnished to a qualified individual in connection with participation in an approved clinical trial. A health insurer shall not be required to pay for costs of items, services, or drugs that are customarily provided by the sponsors of an approved clinical trial.</text>
  </para>
  <para>
    <num>(b)</num>
    <text>In the case of health care services provided by a participating provider, the payment rate shall be at the network negotiated rate, based on the member’s plan design. In case of a non-participating provider, the payment shall be at the rate that the member’s plan would otherwise pay to a non-participating provider for the same services, less any applicable co-payments and deductibles.</text>
  </para>
  <annotations>
    <annotation doc="D.C. Law 17-166" type="History" path="§3">June 5, 2008, D.C. Law 17-166, § 3, 55 DCR 5174</annotation>
  </annotations>
</section>
